Cara Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.

About CARA

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. 

CEO
Christopher Posner
CEOChristopher Posner
Employees
84
Employees84
Headquarters
Stamford, Connecticut
HeadquartersStamford, Connecticut
Founded
2004
Founded2004
Employees
84
Employees84

CARA Key Statistics

Market cap
456.13M
Market cap456.13M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
425.10K
Average volume425.10K
High today
$8.73
High today$8.73
Low today
$8.38
Low today$8.38
Open price
$8.67
Open price$8.67
Volume
327.50K
Volume327.50K
52 Week high
$18.93
52 Week high$18.93
52 Week low
$7.40
52 Week low$7.40

CARA News

Simply Wall St 7d
Independent Chairman & Lead Independent Director Martin Vogelbaum Just Sold A Bunch Of Shares In Cara Therapeutics, Inc. - Simply Wall St

Anyone interested in Cara Therapeutics, Inc. ( ) should probably be aware that the Independent Chairman & Lead Independent Director, Martin Vogelbaum, recently...

Independent Chairman & Lead Independent Director Martin Vogelbaum Just Sold A Bunch Of Shares In Cara Therapeutics, Inc. - Simply Wall St

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

CARA Earnings

-$0.63
$0.11
$0.85
$1.59
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, After Hours
ActualExpected Nov 7, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.